Trevi Therapeutics, Inc. Quarterly Operating Lease, Payments in USD from Q1 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Trevi Therapeutics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2018 to Q3 2024.
  • Trevi Therapeutics, Inc. Operating Lease, Payments for the quarter ending September 30, 2024 was $78K, a 13% increase year-over-year.
  • Trevi Therapeutics, Inc. Operating Lease, Payments for the twelve months ending September 30, 2024 was $285K, a 44.7% increase year-over-year.
  • Trevi Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $231K, a 77.7% increase from 2022.
  • Trevi Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $130K, a 6.48% decline from 2021.
  • Trevi Therapeutics, Inc. annual Operating Lease, Payments for 2021 was $139K, a 0.73% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $285K $78K +$9K +13% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $276K $69K $0 0% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $276K $69K +$45K +188% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $231K $69K +$34K +97.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-20
Q3 2023 $197K $69K +$33K +91.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 $164K $69K +$45K +188% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $119K $24K -$11K -31.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $130K $35K $0 0% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-20
Q3 2022 $130K $36K +$1K +2.86% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $129K $24K -$11K -31.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $140K $35K +$1K +2.94% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $139K $35K $0 0% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-16
Q3 2021 $139K $35K +$12K +52.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $127K $35K $0 0% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $127K $34K -$11K -24.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $138K $35K +$2K +6.06% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-17
Q3 2020 $136K $23K -$11K -32.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $147K $35K +$12K +52.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $135K $45K +$10K +28.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $125K $33K +$11K +50% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-25
Q3 2019 $114K $34K -$5K -12.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $119K $23K -$7K -23.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $126K $35K +$9K +34.6% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $117K $22K Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 $39K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $30K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-12
Q1 2018 $26K Jan 1, 2018 Mar 31, 2018 10-Q 2019-06-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.